-
Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19
PRNewswire
February 27, 2020
Active Motif Shanghai (a subsidiary of Active Motif, Inc.), in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic™ screening technology to isolate antibodies from patients recovering from 2019
-
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
Wuxi Biologics
February 26, 2020
WuXi Biologics and Vir Biotechnology, Inc. announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of Coronavirus Disease 2019 (COVID-19), a disease caused by Severe Acute Resp
-
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect
prnasia
February 25, 2020
Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations.
-
Antibody Production Successfully Induced in the First Batch of Vaccines
fmprc
February 25, 2020
Song Zhiheng, deputy head of the Science and Technology Department of Zhejiang Province, said that the first batch of vaccines has successfully induced antibody production and entered the stage of animal test.
-
Chinese Scientist Unite Together to Tackle With COVID-19
PRNewswire
February 20, 2020
As to the battle against the COVID-19, Chinese Ministry of Science and Technology (MOST) has been launched the program of "Dealing With the Outbreak of COVID-19 Using Science and Technology".
-
Mankind should share sorrows when facing COVID-19
PRNewswire
February 20, 2020
A news report by China.org.cn on some Western media's virus-related xenophobic comments against China.
-
NHC: Early Diagnosis and Treatment Brings the Proportion of Severe NCP Cases Down from 38% to 18%
fmprc
February 19, 2020
On the afternoon of 17 February, the State Council inter-agency task force on responding to the novel coronavirus pneumonia (NCP, or COVID-19) outbreak held a press briefing on the latest progress in medical treatment of NCP cases.
-
Singapore-Based Novocall Announces US$100,000 'Call for Care' Initiative to Support Frontline Healthcare Service Providers from Countries Affected by COVID-19
prnasia
February 17, 2020
Call automation software company Novocall, announces today that it has set up a US$100,000 fund under its 'Call For Care' initiative.
-
Center For Biocide Chemistries Publishes List Of Products That Help Stop Spread Of Novel Coronavirus
PRNewswire
February 17, 2020
The Center for Biocide Chemistries (CBC) is helping federal, state, and local health agencies -- as well as the general public -- fight back against the spread of the 2019 novel coronavirus, COVID-19.
-
WHO chief calls for solidarity in fighting epidemics
Xinhuanet
February 17, 2020
The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus on Saturday called for solidarity in fighting the epidemics here at the 56th Munich Security Conference (MSC).